129 filings
Page 2 of 7
8-K
ohhh62b6j0o4a
25 Apr 22
Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations
7:12am
8-K
4x2l86dmlo
21 Apr 22
Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors
8:08am
8-K
jrgdvbp1 30hi
1 Mar 22
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2021 Financial Results and Provides Corporate Update
7:49am
8-K
rrj6w fzd3r9uwto
7 Jan 22
Other Events
4:12pm
8-K
dbayt 38s21l3qh
5 Jan 22
Entry into a Material Definitive Agreement
5:06pm
8-K
czg8agha8u17 zu9s
5 Jan 22
Financial Statements and Exhibits
4:58pm
8-K
svuhlsgcpu 5o
4 Jan 22
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
12:00am
8-K
7fyj7la4
29 Dec 21
Entry into a Material Definitive Agreement
4:11pm
8-K
djk jte8v
20 Dec 21
Intra-Cellular Therapies Announces U.S. FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression in Adults
7:04am
8-K
d2biokb
8 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:33pm
8-K
dgqrlc611ub95st he7
9 Nov 21
Intra-cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update
7:49am
8-K
p0ky0wn4iy
9 Aug 21
Intra-cellular Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update
7:37am
8-K
u4u5v iacb9oe12y8s3h
22 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:09pm
8-K
992qh2hmkr 231og77
10 May 21
Intra-cellular Therapies Reports First Quarter 2021 Financial Results and Provides Corporate Update
7:37am
8-K
0s59z8d gjv2l
3 May 21
Intra-Cellular Therapies Announces FDA Acceptance of CAPLYTA® (lumateperone) sNDAs for the Treatment of Bipolar Depression
7:42am
8-K
ctid6mdm8wc
25 Feb 21
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2020 Financial Results and Provides Corporate Update
7:54am
8-K
xpjn8i4s
22 Feb 21
Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression
8:09am
8-K
uum1js507 dz
9 Nov 20
Intra-cellular Therapies Reports Third Quarter 2020 Financial Results and Provides Corporate Update
7:40am
8-K
w85hbtk vk25
1 Oct 20
Intra-Cellular Therapies Announces the Appointment of Dr. Suresh Durgam as Chief Medical Officer
4:38pm
8-K
baxn6fldxzz oa0ldbh
11 Sep 20
Entry into a Material Definitive Agreement
4:47pm